Sun Pharma Advanced Research Company has informed that the meeting of the Board of Directors of the Company is scheduled on 01/09/2021 to consider and approve/ evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. In this connection, as per the Company's code of conduct for prevention of insider trading, the trading window for dealing or trading in securities of the Company will remain closed with immediate effect for all directors, designated persons and insiders and shall re-open after the expiry of 48 hours after the conclusion of the aforesaid Board Meeting.
The above information is a part of company’s filings submitted to BSE.
